Inaktiver Wert

Ardea Biosciences, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

SANOFI : AstraZeneca hungry to refill medicine cabinet	30.06.12
SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	09.05.12
Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	02.05.12
Ardea Biosciences, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Ardea Biosciences, Inc.	01.05.12
Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	30.04.12

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-2,63 %	103 Mrd.
REGENERON PHARMACEUTICALS, INC.	+1,62 %	95,28 Mrd.
ARGENX SE	+1,46 %	22,15 Mrd.
BIONTECH SE	-16,67 %	21,02 Mrd.
GENMAB A/S	-8,58 %	18,15 Mrd.
WUXI APPTEC CO., LTD.	-38,74 %	16,73 Mrd.
BEIGENE, LTD.	-13,21 %	16,05 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+5,41 %	13,68 Mrd.
SAREPTA THERAPEUTICS, INC.	+33,57 %	12,17 Mrd.